Brief: Ikena Oncology Q2 EPS USD -0.44
10/08/2023 13:09
Aug 10 (Reuters) - Ikena Oncology Q2 net income USD -17.115 million. * Q2 operating expenses USD 20.494 million * Q2 EPS USD -0.44 * Q2 revenue USD 2.004 million vs. IBES estimate USD 3.08 million * Q2 operating income USD -18.49 million
Recent news on ImageneBio
See all newsU.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune
U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma
Brief: ImageneBio Inc - On Oct 23, Elects Not To Renew Agreement With Miragene - SEC Filing
ImageneBio Inc expected to post a loss of $1.56 a share - Earnings Preview
Brief: Ikena Oncology Announces Stockholder Approval Of Merger With Inmagene Biopharmaceuticals